← FDA Drug Approvals (Drugs@FDA)

ENSPRYNG

BLA · Biologics License Application · Sponsor: GENENTECH · Approved 2020-08-14

Drug application

FDA Application #

BLA761149

Application type

Biologics License Application

Brand name

ENSPRYNG

Generic name

SATRALIZUMAB

Active ingredients

SATRALIZUMAB

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

GENENTECH

Manufacturer

Genentech, Inc.

First approval

2020-08-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown